Press "Enter" to skip to content

New patent for Blueprint Medicines drug AYVAKIT

0
Copyright © DrugPatentWatch. Originally published at New patent for Blueprint Medicines drug AYVAKIT

Annual Drug Patent Expirations for AYVAKIT
Annual Drug Patent Expirations for AYVAKIT

Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-one patent family members in twenty-eight countries.

The generic ingredient in AYVAKIT is avapritinib. Additional details are available on the avapritinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Blueprint Medicines drug AYVAKIT
DrugPatentWatch - Make Better Decisions